UKPDS - modelling of cardiovascular risk assessment and lifetime simulation of outcomes

被引:20
作者
Adler, A. I. [1 ]
机构
[1] Addenbrookes Hosp, Inst Metab Sci, Cambridge CB2 2QQ, England
关键词
cardiovascular disease; epidemiology; health economics; modelling;
D O I
10.1111/j.1464-5491.2008.02498.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although known principally, as a clinical trial, the UK Prospective Diabetes Study (UKPDS) provided longitudinal data which helped define the natural history of cardiovascular complications in Type 2 diabetes. Using clinical, epidemiological, statistical and economics methods, UKPDS investigators developed mathematical models that helped define predictors (risk factors) for cardiovascular disease including angina, myocardial infarction, stroke, peripheral Vascular disease and death in Type 2 diabetes. The UKPDS made clearer the contributions to risk of age, hyperglycaemia, elevated blood pressure, adverse blood lipids and smoking. Equations were developed, combined and incorporated into the UKPDS Risk Engine and the UKPDS Outcomes models. For example, the UKPDS risk engine-version 2-estimates that a white 62-year-old man with 11 years of Type 2 diabetes, a glycated haemoglobin of 8.3%, a systolic blood pressure of 145 mmHg and total and high-density lipoprotein cholesterol values of 5.8 and 1.1 mmol/l who did not smoke has a 33% chance of having overt coronary heart disease within 10 years. These models Contribute to the estimation of risk and/or health outcomes adjusted for quality of life for use by, amongst others, clinicians, trialists, health planners, guideline developers and health economists.
引用
收藏
页码:41 / 46
页数:6
相关论文
共 50 条
  • [31] Cardiovascular risk assessment, cardiovascular disease risk factors, and lung function parameters
    Polak, Maciej
    Dorynska, Agnieszka
    Szafraniec, Krystyna
    Pajak, Andrzej
    KARDIOLOGIA POLSKA, 2018, 76 (07) : 1055 - 1063
  • [32] Benefits and pitfalls of cardiovascular risk assessment
    Poulter, NR
    JOURNAL OF HUMAN HYPERTENSION, 2000, 14 (Suppl 2) : S11 - S16
  • [33] Cardiovascular risk assessment in patients with diabetes
    Marcello Casaccia Bertoluci
    Viviane Zorzanelli Rocha
    Diabetology & Metabolic Syndrome, 9
  • [34] Benefits and pitfalls of cardiovascular risk assessment
    NR Poulter
    Journal of Human Hypertension, 2000, 14 : S11 - S16
  • [35] Cardiovascular risk assessment in women - an update
    Collins, P.
    Webb, C. M.
    de Villiers, T. J.
    Stevenson, J. C.
    Panay, N.
    Baber, R. J.
    CLIMACTERIC, 2016, 19 (04) : 329 - 336
  • [36] Cardiovascular risk assessment in patients with diabetes
    Bertoluci, Marcello Casaccia
    Rocha, Viviane Zorzanelli
    DIABETOLOGY & METABOLIC SYNDROME, 2017, 9
  • [37] Cardiovascular risk assessment tools in Asia
    Zhang, Yuqing
    Miao, Huanhuan
    Chia, Yook-Chin
    Buranakitjaroen, Peera
    Siddique, Saulat
    Shin, Jinho
    Turana, Yuda
    Park, Sungha
    Tsoi, Kelvin
    Chen, Chen-Huan
    Cheng, Hao-Min
    Li, Yan
    Huynh Van Minh
    Nagai, Michiaki
    Nailes, Jennifer
    Sison, Jorge
    Soenarta, Arieska Ann
    Sogunuru, Guru Prasad
    Sukonthasarn, Apichard
    Tay, Jam Chin
    Teo, Boon Wee
    Verma, Narsingh
    Wang, Tzung-Dau
    Hoshide, Satoshi
    Kario, Kazuomi
    Wang, Jiguang
    JOURNAL OF CLINICAL HYPERTENSION, 2022, 24 (04) : 369 - 377
  • [38] Guidelines on cardiovascular risk assessment and management
    Wood, DA
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2005, 7 (0L) : L5 - L10
  • [39] Cardiovascular risk assessment in haemophilia patients
    Biere-Rafi, Sara
    Baarslag, Manuel A.
    Peters, Marjolein
    Kruip, Marieke J. H. A.
    Kraaijenhagen, Roderik A.
    Den Heijer, Martin
    Buller, Harry R.
    Kamphuisen, Pieter W.
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (02) : 274 - 278
  • [40] Cardiovascular Risk Assessment in the Older Athlete
    Moorman, Alec J.
    Dean, Larry S.
    Yang, Eugene
    Drezner, Jonathan A.
    SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH, 2021, 13 (06): : 622 - 629